
ICR responds to NICE approval of palbociclib for treating advanced breast cancer after hormone therapy
The Institute of Cancer Research, London, welcomes the approval by NICE of the innovative targeted…
The Institute of Cancer Research, London, welcomes the approval by NICE of the innovative targeted…
A new blood test for women with breast cancer can predict how well patients will…
A recently-approved breast cancer drug could be used to target and treat a life-threatening leukaemia,…
A new study has found a blood test for cancer DNA could predict if a…
Two challenges in treating patients with estrogen-positive breast cancer (ER+) have been an inability to…
Scientists at Winship Cancer Institute of Emory University have mapped a vast spider web of…
Phase 1 clinical trial data published this week in the journal Clinical Cancer Research show early promise of…
New practice changing clinical trial results show that for postmenopausal women with advanced or metastatic…